Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
JSPR:NASDAQ
Jasper Therapeutics Inc
0,93 US$
-0,61%
(-0,0057) 1D
1 may, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Açın
0,94 US$
High
0,96 US$
Low
0,92 US$
Mkt. cap
25,93 mln
Avg. vol.
531,90K
Volume
222,70K
52-wk high
7,19 US$
52-wk low
0,62 US$
EPS
-3,95 US$
Beta
3,20
Shares outstanding
28,00 mln
No. of employees
22
News stories
From sources across the web
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersRedwood City, Kaliforniya, Amerika Birləşmiş Ştatları
Sector-
Websitejaspertx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
16,16 mln
21,20 mln
13,10 mln
10,85 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,64 mln
5,88 mln
4,26 mln
4,49 mln
Operating expense
21,80 mln
27,08 mln
17,36 mln
15,35 mln
Total operating expenses
21,80 mln
27,08 mln
17,36 mln
15,35 mln
Operating income
-21,80 mln
-27,08 mln
-17,36 mln
-15,35 mln
Other non operating income
-63,00K
-84,00K
88,00K
6,40 mln
EBT including unusual items
-21,24 mln
-26,72 mln
-18,74 mln
-9,10 mln
EBT excluding unusual items
-21,24 mln
-26,72 mln
-16,93 mln
-8,61 mln
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,24 mln
-26,72 mln
-18,74 mln
-9,10 mln
Net profit margin
-
-
-
-
Earnings per share
-1,41
-1,74
-1,25
-0,54
Interest and investment income
624,00K
437,00K
342,00K
338,00K
Interest expense
-
-
-
-
Net interest expenses
624,00K
437,00K
342,00K
338,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,52 mln
-26,82 mln
-17,13 mln
-15,06 mln
Gain or loss from assets sale
-
2,00K
-2,00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer